Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 13-Jun-23 12:07 PM View:  | Buchi J Kevin Director | Ampio Pharmaceuticals, Inc. (AMPE) | 09-Jun-23 | Private Purchase | 21,858 | $0.29 | $6,284.17 | 17% 125.0K to 146.86K | |
| 09-Jun-23 2:26 PM View: | Buchi J Kevin Director | Ampio Pharmaceuticals, Inc. (AMPE) | 08-Jun-23 | Private Purchase | 25,000 | $0.30 | $7,400.00 | 25% 100.0K to 125.0K | |
| 26-May-23 1:30 PM View: | Martino Michael A CEO Director | Ampio Pharmaceuticals, Inc. (AMPE) | 24-May-23 | Private Purchase | 76,890 | $0.29 | $22,121.30 | 100% 0 to 76.89K | |
| 17-May-23 4:25 PM View: | Buchi J Kevin Director | Ampio Pharmaceuticals, Inc. (AMPE) | 16-May-23 | Private Purchase | 32,534 | $0.27 | $8,924.08 | 48% 67.47K to 100.0K | |
| 16-May-23 3:30 PM View: | Buchi J Kevin Director | Ampio Pharmaceuticals, Inc. (AMPE) | 15-May-23 | Purchase | 44,026 | $0.25 | $10,856.80 | 188% 23.44K to 67.47K | |
| 12-May-23 5:26 PM View: | Stevens David R Director | Ampio Pharmaceuticals, Inc. (AMPE) | 12-May-23 | Purchase | 45,000 | $0.22 | $9,900.00 | 76% 58.97K to 103.97K | |
| 16-May-23 3:30 PM View: | Buchi J Kevin Director | Ampio Pharmaceuticals, Inc. (AMPE) | 12-May-23 | Private Purchase | 23,440 | $0.24 | $5,513.09 | 100% 0 to 23.44K | |
| 12-May-23 5:26 PM View: | Stevens David R Director | Ampio Pharmaceuticals, Inc. (AMPE) | 11-May-23 | Private Purchase | 50,000 | $0.22 | $10,875.00 | 557% 8.97K to 58.97K | |
| 04-Jan-22 6:31 PM View: | MacAluso Michael Director | Ampio Pharmaceuticals, Inc. (AMPE) | 01-Jan-22 | Payment of Exercise | 68,400 | $0.57 | $38,988.00 | (3%) 2.69M to 2.62M | (6%) |
| 04-Jan-22 6:35 PM View: | Stokely Dan CFO | Ampio Pharmaceuticals, Inc. (AMPE) | 01-Jan-22 | Payment of Exercise | 22,914 | $0.57 | $13,061.00 | (7%) 335.19K to 312.27K | (6%) |
| 04-Jan-22 6:33 PM View: | Cherevka Holli PRESIDENT AND COO | Ampio Pharmaceuticals, Inc. (AMPE) | 01-Jan-22 | Payment of Exercise | 47,200 | $0.57 | $26,904.00 | (10%) 458.02K to 410.82K | (6%) |
| 28-Oct-21 8:30 PM View: | MacAluso Michael CEO Director | Ampio Pharmaceuticals, Inc. (AMPE) | 27-Oct-21 | Payment of Exercise | 43,470 | $1.64 | $71,290.80 | (2%) 2.74M to 2.69M | |
| 28-Oct-21 8:32 PM View: | Cherevka Holli PRESIDENT AND COO | Ampio Pharmaceuticals, Inc. (AMPE) | 27-Oct-21 | Payment of Exercise | 41,980 | $1.64 | $68,847.20 | (8%) 500.0K to 458.02K | |
| 28-Oct-21 8:34 PM View: | Stokely Dan CFO | Ampio Pharmaceuticals, Inc. (AMPE) | 27-Oct-21 | Payment of Exercise | 28,127 | $1.64 | $46,128.30 | (8%) 363.31K to 335.19K | |
| 13-Oct-21 7:35 PM View: | Stokely Dan CFO | Ampio Pharmaceuticals, Inc. (AMPE) | 11-Oct-21 | Grant | 335,000 | -- | -- | 1183% 28.32K to 363.31K | |
| 13-Oct-21 7:33 PM View: | Cherevka Holli Chief Operating Officer | Ampio Pharmaceuticals, Inc. (AMPE) | 11-Oct-21 | Grant | 500,000 | -- | -- | 100% 0 to 500.0K | |
| 13-Oct-21 7:37 PM View: | MacAluso Michael CEO Director | Ampio Pharmaceuticals, Inc. (AMPE) | 11-Oct-21 | Grant | 950,000 | -- | -- | 53% 1.79M to 2.74M | |
| 29-Jun-21 11:22 AM View: | Stokely Dan CFO | Ampio Pharmaceuticals, Inc. (AMPE) | 25-Jun-21 | Option Exercise | 22,500 | $0.43 | $9,675.00 | 79% 28.32K to 50.81K | |
| 29-Jun-21 11:22 AM View: | Stokely Dan CFO | Ampio Pharmaceuticals, Inc. (AMPE) | 25-Jun-21 | Market Option Sale | 22,500 | $1.79 | $40,275.00 | (44%) 50.81K to 28.32K | |
| 25-May-21 3:45 PM View: | Cherevka Holli Chief Operating Officer | Ampio Pharmaceuticals, Inc. (AMPE) | 21-May-21 | Option Exercise | 2,603 | $0.51 | $1,327.53 | 100% 0 to 2.6K | |
| 25-May-21 3:44 PM View: | Coelho Philip H Director | Ampio Pharmaceuticals, Inc. (AMPE) | 21-May-21 | Option Exercise | 6,737 | $0.40 | $2,694.80 | 3% 203.5K to 210.24K | |
| 25-May-21 3:45 PM View: | Cherevka Holli Chief Operating Officer | Ampio Pharmaceuticals, Inc. (AMPE) | 21-May-21 | Market Option Sale | 2,603 | $2.00 | $5,206.00 | (100%) 2.6K to 0 | |
| 25-May-21 3:44 PM View: | Coelho Philip H Director | Ampio Pharmaceuticals, Inc. (AMPE) | 21-May-21 | Market Option Sale | 6,737 | $2.00 | $13,474.00 | (3%) 210.24K to 203.5K | |
| 19-May-21 5:56 PM View: | Stokely Dan CFO | Ampio Pharmaceuticals, Inc. (AMPE) | 18-May-21 | Market Option Sale | 35,000 | $1.83 | $63,980.00 | (55%) 63.31K to 28.32K | |
| 19-May-21 5:56 PM View: | Stokely Dan CFO | Ampio Pharmaceuticals, Inc. (AMPE) | 17-May-21 | Option Exercise | 35,000 | $0.43 | $15,050.00 | 124% 28.32K to 63.31K | |
| 29-Apr-21 9:37 PM View: | Coelho Philip H Director | Ampio Pharmaceuticals, Inc. (AMPE) | 29-Apr-21 | Market Option Sale | 3,263 | $2.00 | $6,526.00 | (2%) 206.76K to 203.5K | |
| 29-Apr-21 9:37 PM View: | Coelho Philip H Director | Ampio Pharmaceuticals, Inc. (AMPE) | 29-Apr-21 | Option Exercise | 3,263 | $0.40 | $1,305.20 | 2% 203.5K to 206.76K | |
| 29-Apr-21 9:36 PM View: | Cherevka Holli Chief Operating Officer | Ampio Pharmaceuticals, Inc. (AMPE) | 27-Apr-21 | Market Option Sale | 74,631 | $2.00 | $149,262.00 | (100%) 74.63K to 0 | |
| 29-Apr-21 9:38 PM View: | Coelho Philip H Director | Ampio Pharmaceuticals, Inc. (AMPE) | 27-Apr-21 | Market Option Sale | 20,000 | $2.00 | $40,000.00 | (9%) 223.5K to 203.5K | |
| 29-Apr-21 9:36 PM View: | Cherevka Holli Chief Operating Officer | Ampio Pharmaceuticals, Inc. (AMPE) | 27-Apr-21 | Option Exercise | 74,631 | $0.51 | $38,061.80 | 100% 0 to 74.63K | |
| 29-Apr-21 9:38 PM View: | Coelho Philip H Director | Ampio Pharmaceuticals, Inc. (AMPE) | 27-Apr-21 | Option Exercise | 20,000 | $0.40 | $8,000.00 | 10% 203.5K to 223.5K | |
| 17-Mar-21 6:35 PM View: | Stokely Dan CFO | Ampio Pharmaceuticals, Inc. (AMPE) | 16-Mar-21 | Option Exercise | 40,000 | $0.43 | $17,200.00 | 141% 28.32K to 68.31K | |
| 17-Mar-21 6:35 PM View: | Stokely Dan CFO | Ampio Pharmaceuticals, Inc. (AMPE) | 16-Mar-21 | Market Option Sale | 40,000 | $1.83 | $73,048.00 | (59%) 68.31K to 28.32K | |
| 17-Feb-21 2:51 PM View: | Stokely Dan CFO | Ampio Pharmaceuticals, Inc. (AMPE) | 12-Feb-21 | Payment of Exercise | 24,185 | $2.55 | $61,671.80 | (46%) 52.5K to 28.32K | 8% |
| 17-Feb-21 2:51 PM View: | Stokely Dan CFO | Ampio Pharmaceuticals, Inc. (AMPE) | 12-Feb-21 | Option Exercise | 52,500 | $2.55 | $133,875.00 | 100% 0 to 52.5K | (8%) |
| 05-Jan-21 4:57 PM View: | Stevens David R Director | Ampio Pharmaceuticals, Inc. (AMPE) | 04-Jan-21 | Grant | 13,513 | $1.48 | $19,999.20 | 11% 121.05K to 134.56K | 0% |
| 05-Jan-21 4:59 PM View: | Bar-Or David Director | Ampio Pharmaceuticals, Inc. (AMPE) | 04-Jan-21 | Grant | 13,513 | $1.48 | $19,999.20 | 17% 79.29K to 92.8K | 0% |
| 05-Jan-21 4:58 PM View: | Coelho Philip H Director | Ampio Pharmaceuticals, Inc. (AMPE) | 04-Jan-21 | Grant | 13,513 | $1.48 | $19,999.20 | 7% 189.99K to 203.5K | 0% |
| 05-Jan-21 4:59 PM View: | Giles Richard B Director | Ampio Pharmaceuticals, Inc. (AMPE) | 04-Jan-21 | Grant | 13,513 | $1.48 | $19,999.20 | 4% 353.61K to 367.12K | 0% |
| 06-Jan-20 4:07 PM View: | Bar-Or David Director | Ampio Pharmaceuticals, Inc. (AMPE) | 02-Jan-20 | Grant | 34,059 | $0.59 | $19,999.40 | 75% 45.23K to 79.29K | 413% |
| 06-Jan-20 4:08 PM View: | Coelho Philip H Director | Ampio Pharmaceuticals, Inc. (AMPE) | 02-Jan-20 | Grant | 34,059 | $0.59 | $19,999.40 | 22% 155.93K to 189.99K | 413% |
| 06-Jan-20 4:07 PM View: | Giles Richard B Director | Ampio Pharmaceuticals, Inc. (AMPE) | 02-Jan-20 | Grant | 34,059 | $0.59 | $19,999.40 | 11% 319.55K to 353.61K | 413% |
| 06-Jan-20 4:08 PM View: | Stevens David R Director | Ampio Pharmaceuticals, Inc. (AMPE) | 02-Jan-20 | Grant | 34,059 | $0.59 | $19,999.40 | 39% 86.99K to 121.05K | 413% |
| 21-Oct-19 4:34 PM View: | Bar-Or David Director | Ampio Pharmaceuticals, Inc. (AMPE) | 17-Oct-19 | Grant | 45,228 | $0.44 | $19,999.80 | 100% 0 to 45.23K | 583% |
| 04-Jan-19 4:43 PM View: | Coelho Philip H Director | Ampio Pharmaceuticals, Inc. (AMPE) | 02-Jan-19 | Grant | 45,454 | $0.44 | $19,999.80 | 41% 110.47K to 155.93K | 648% |
| 04-Jan-19 4:44 PM View: | Giles Richard B Director | Ampio Pharmaceuticals, Inc. (AMPE) | 02-Jan-19 | Grant | 45,454 | $0.44 | $19,999.80 | 17% 274.1K to 319.55K | 648% |
| 04-Jan-19 4:44 PM View: | Stevens David R Director | Ampio Pharmaceuticals, Inc. (AMPE) | 02-Jan-19 | Grant | 45,454 | $0.44 | $19,999.80 | 109% 41.54K to 86.99K | 648% |
| 29-Jan-18 5:10 PM View: | Stevens David R Director | Ampio Pharmaceuticals, Inc. (AMPE) | 25-Jan-18 | Grant | 5,747 | $3.48 | $19,999.60 | 16% 35.79K to 41.54K | |
| 29-Jan-18 5:08 PM View: | Coelho Philip H Director | Ampio Pharmaceuticals, Inc. (AMPE) | 25-Jan-18 | Grant | 5,747 | $3.48 | $19,999.60 | 5% 104.73K to 110.47K | |
| 29-Jan-18 5:09 PM View: | Giles Richard B Director | Ampio Pharmaceuticals, Inc. (AMPE) | 25-Jan-18 | Grant | 5,747 | $3.48 | $19,999.60 | 2% 268.35K to 274.1K |
